Rickman John M D (66 results)
Published by Garden City, N.Y. Doubleday & Company, Inc. 1957, 1957
- Softcover
Seller: Black and Read Books, Music & Games, Arvada, CO, U.S.A.Black and Read Books, Music & Games
Contact seller3-star sellerReprint edition. Mild shelf wear to the wraps. Rubbing to the head / tail of the spine. Top / bottom edge of the pages / free endpaper have light stamps. The internal pages are clean and the binding is sound. A solid copy.
Published by Leonard & Vierginal Woolf at the Hagarth Press, 1926
- Hardcover
Seller: 2Vbooks, Derwood, MD, U.S.A.2Vbooks
Contact seller5-star sellerHard cover. Condition: Very good. No dust jacket. No. 11. 471 p. No previous owner's name but a few pencil notes on black page. Clean, tight pages. No bent corners. No remainder mark. eb 102.
Published by Doubleday Anchor
- Softcover
Seller: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contact seller5-star sellerCondition: Used - Very good
£ 14.95
£ 7.87 shippingShips within U.S.A.Quantity: 2 available
Condition: Very Good. 1957. Paperback. Vintage paperback. Good clean condition with some minor reader wear. . . . . Books ship from the US and Ireland.
Published by Doubleday Anchor, 1957
- Softcover
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrelandKennys Bookshop and Art Galleries Ltd.
Contact seller5-star sellerCondition: Used - Very good
£ 19.00
£ 8.99 shippingShips from Ireland to U.S.A.Quantity: 2 available
Condition: Very Good. 1957. Paperback. Vintage paperback. Good clean condition with some minor reader wear. . . . .
Language: English
Published by Cham, Springer., 2018
Series: Advances in Experimental Medicine and Biology, Book 490 of 490. Book 490 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, GermanyUniversitätsbuchhandlung Herta Hold GmbH
Contact seller4-star sellerCondition: Used
£ 23.82
£ 25.69 shippingShips from Germany to U.S.A.Quantity: 7 available
xlii, 669 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Softcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: New
£ 189.03
£ 15.00 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New.
Language: English
Published by Springer, 2016
Series: Advances in Experimental Medicine and Biology, Book 21 of 490. Book 21 of 490 - Advances in Experimental Medicine and Biology
- Softcover
Seller: Phatpocket Limited, Waltham Abbey, HERTS, United KingdomPhatpocket Limited
Contact seller5-star sellerCondition: Used - Good
£ 199.43
£ 10.64 shippingShips from United Kingdom to U.S.A.Quantity: 1 available
Condition: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Softcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: Used - As new
£ 214.39
£ 15.00 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: As New. Unread book in perfect condition.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
£ 264.74
£ 1.98 shippingShips within U.S.A.Quantity: Over 20 available
Condition: New.
Language: English
Published by Springer, 2014
Series: Advances in Experimental Medicine and Biology, Book 21 of 490. Book 21 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 260.72
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
- Softcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 260.72
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Springer, 2018
Series: Advances in Experimental Medicine and Biology, Book 490 of 490. Book 490 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 260.72
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Springer International Publishing, 2018
Series: Advances in Experimental Medicine and Biology, Book 490 of 490. Book 490 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
£ 236.27
£ 41.95 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Gebunden. Condition: New.
- Softcover
Seller: moluna, Greven, Germanymoluna
Contact seller5-star sellerCondition: New
£ 236.27
£ 41.95 shippingShips from Germany to U.S.A.Quantity: Over 20 available
Condition: New.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Lavail, Matthew M. (EDT); Anderson, Robert E. (EDT); Grimm, Christian (EDT); Hollyfield, Joe (EDT)
- Softcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
£ 301.52
£ 1.98 shippingShips within U.S.A.Quantity: Over 20 available
Condition: As New. Unread book in perfect condition.
More images- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 242.22
£ 59.95 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Retinal Degenerative Diseases | Mechanisms and Experimental Therapy | John D. Ash (u. a.) | Taschenbuch | Advances in Experimental Medicine and Biology | xlii | Englisch | 2019 | Springer | EAN 9783030092214 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelber…g, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
More imagesLanguage: English
Published by Springer, 2016
Series: Advances in Experimental Medicine and Biology, Book 21 of 490. Book 21 of 490 - Advances in Experimental Medicine and Biology
- Softcover
Seller: preigu, Osnabrück, Germanypreigu
Contact seller5-star sellerCondition: New
£ 242.22
£ 59.95 shippingShips from Germany to U.S.A.Quantity: 5 available
Taschenbuch. Condition: Neu. Retinal Degenerative Diseases | Mechanisms and Experimental Therapy | John D. Ash (u. a.) | Taschenbuch | lxi | Englisch | 2016 | Springer | EAN 9781493952762 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anb…ieter: preigu.
Language: English
Published by Springer, 2021
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Softcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 291.44
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Language: English
Published by Springer, 2019
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: Ria Christie Collections, Uxbridge, United KingdomRia Christie Collections
Contact seller5-star sellerCondition: New
£ 291.44
£ 11.98 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New. In.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Language: English
Published by Springer, 2019
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: New
£ 291.43
£ 15.00 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: New.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Language: English
Published by Springer, 2019
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: New
£ 319.48
£ 1.98 shippingShips within U.S.A.Quantity: Over 20 available
Condition: New.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Language: English
Published by Springer, 2019
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: GreatBookPrices, Columbia, MD, U.S.A.GreatBookPrices
Contact seller5-star sellerCondition: Used - As new
£ 334.50
£ 1.98 shippingShips within U.S.A.Quantity: Over 20 available
Condition: As New. Unread book in perfect condition.
Retinal Degenerative Diseases : Mechanisms and Experimental Therapy
Rickman, Catherine Bowes (EDT); Grimm, Christian (EDT); Anderson, Robert E. (EDT); Ash, John D. (EDT); Lavail, Matthew M. (EDT)
Language: English
Published by Springer, 2019
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: GreatBookPricesUK, Woodford Green, United KingdomGreatBookPricesUK
Contact seller5-star sellerCondition: Used - As new
£ 321.44
£ 15.00 shippingShips from United Kingdom to U.S.A.Quantity: Over 20 available
Condition: As New. Unread book in perfect condition.
Language: English
Published by Springer, 2019
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: California Books, Miami, FL, U.S.A.California Books
Contact seller4-star sellerCondition: New
£ 344.40
Free ShippingShips within U.S.A.Quantity: Over 20 available
Condition: New.
Language: English
Published by Springer, Springer, 2014
Series: Advances in Experimental Medicine and Biology, Book 21 of 490. Book 21 of 490 - Advances in Experimental Medicine and Biology
- Hardcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 286.94
£ 57.94 shippingShips from Germany to U.S.A.Quantity: 1 available
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal deg…enerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
Language: English
Published by Springer, 2021
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Softcover
Seller: Buchpark, Trebbin, GermanyBuchpark
Contact seller5-star sellerCondition: Used
£ 257.74
£ 89.92 shippingShips from Germany to U.S.A.Quantity: 1 available
Condition: Hervorragend. Zustand: Hervorragend | Seiten: 616 | Sprache: Englisch | Produktart: Bücher | This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of…inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the ¿best¿ and ¿most important¿ meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes,cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium, RD2016. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.
Language: English
Published by Springer, Humana, 2016
Series: Advances in Experimental Medicine and Biology, Book 21 of 490. Book 21 of 490 - Advances in Experimental Medicine and Biology
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 294.41
£ 57.25 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited reti…nal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 294.41
£ 55.92 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium wil…l focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2014. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2018 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
Language: English
Published by Springer, 2021
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Softcover
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrelandKennys Bookshop and Art Galleries Ltd.
Contact seller5-star sellerCondition: New
£ 382.49
£ 8.99 shippingShips from Ireland to U.S.A.Quantity: 15 available
Condition: New.
Language: English
Published by Springer International Publishing, Springer Nature Switzerland, 2021
Series: Advances in Experimental Medicine and Biology, Book 396 of 490. Book 396 of 490 - Advances in Experimental Medicine and Biology
- Softcover
Seller: AHA-BUCH GmbH, Einbeck, GermanyAHA-BUCH GmbH
Contact seller5-star sellerCondition: New
£ 330.32
£ 56.27 shippingShips from Germany to U.S.A.Quantity: 1 available
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal dege…nerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field. The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes,cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium, RD2016. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.
